Kirk Chartier - 11 Feb 2026 Form 4 Insider Report for Enova International, Inc. (ENVA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2026, 16:30:03 UTC
Prior SEC filing
09 Feb 2026
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Rahilly, as attorney in fact

Key filing fact

Kirk Chartier filed Form 4 for Enova International, Inc. (ENVA) on 13 Feb 2026.

Key facts

  • This page summarizes Kirk Chartier's Form 4 filing for Enova International, Inc. (ENVA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Feb 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 09 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001483333 Primary reporting owner

Chartier Kirk

Relationship
Chief Strategy Officer
Address
C/O ENOVA INTERNATIONAL, INC., 175 W. JACKSON BOULEVARD, SUITE 600, CHICAGO
Signature
/s/ Sean Rahilly, as attorney in fact
Signature date
13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENVA transaction

Common stock, par value $0.00001 per share

Award

Transaction value
$0
Shares
+4,573
Change %
+4.6%
Price
$0.000000
Shares after
104,972
Date
11 Feb 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENVA transaction Derivative

Non-Qualified Stock Option (right to buy) with limited SAR

Award

Transaction value
$0
Shares
+2,938
Change %
Price
$0.000000
Shares after
2,938
Date
11 Feb 2026
Ownership
Direct
Underlying class
Common stock; par value $0.00001 per share
Underlying amount
2,938
Exercise price
$157.79
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030.

Footnote F2

The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

Footnote F3

The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

Footnote F4

The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .